Skip to content
10-Q

Quarterly Report

ENTEROLOGICS, INC.

0001477932-13-002668

← back to feed
Filed
May 20, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 17, 2013 38.01M sh
Capex Q1 2013 · Mar 31, 2013 $300K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$13K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$644.81K
Operating Cash Flow restated Q1 2013 · Mar 31, 2012 −$149.25K
Stockholders Equity Q1 2013 · Mar 31, 2013 −$381.91K
Stockholders Equity Q1 2013 · Dec 31, 2012 −$352.99K
Current Liabilities Q1 2013 · Mar 31, 2013 $403.78K
Current Liabilities Q1 2013 · Dec 31, 2012 $376.35K
Total Liabilities Q1 2013 · Mar 31, 2013 $470.44K
Total Liabilities Q1 2013 · Dec 31, 2012 $443.02K
Total Assets Q1 2013 · Mar 31, 2013 $88.54K
Total Assets Q1 2013 · Dec 31, 2012 $90.03K
Sga Expense Q1 2013 · Mar 31, 2013 $4.12K
Sga Expense Q1 2013 · Mar 31, 2013 $85.82K
Sga Expense restated Q1 2013 · Mar 31, 2012 $6.55K
Rd Expense Q1 2013 · Mar 31, 2013 $10.97K
Rd Expense Q1 2013 · Mar 31, 2013 $214.79K
Rd Expense Q1 2013 · Mar 31, 2012 $29K
Net Income Q1 2013 · Mar 31, 2013 −$39.92K
Net Income Q1 2013 · Mar 31, 2013 −$1.28M
Net Income restated Q1 2013 · Mar 31, 2012 −$153.39K